ART OF MEDICINE 2017

 

PATHOGENETIC MECHANISMS OF SUSTAINABLE ARTERIAL HYPERTENSION FORMATION AT CHRONIC PSYCHOEMO-TIONAL STRESS AND WAYS OF ITʼS CORRECTION

 

O.I. Gryniv

          Ivano-Frankivsk National Medical University, Department of Therapy and Family Medicine of Postgraduate Education, Ivano-Frankivsk, Ukraine, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

  

Abstract

Abstract. The article is devoted to the study of the relationship between psycho-emotional disorders with neurodegenerative and hormonal changes and the study of the effectiveness of the administration of magnesium and mebicer drugs to patients with arterial hypertension. The paper presents new data on the peculiarities of the formation of persistent arterial hypertension in the psycho-emotional imbalance in which stress reactions, accompanied by metabolic changes (mediator mechanisms), are triggered. The use of magnesium and mebicer for 4 weeks has been proved in patients with hypertension to optimize their emotional state, the degree of psychological stress, which was expressed in reducing the manifestations of depression, alexithymia and anxiety. There was also a resumption of the synergistic functioning of the mediator provided with the emotional and vegetative axis, which was expressed by the normalization of levels of norepinephrine, serotonin and cortisol.

All 145 patients with stage II AG, aged 29 to 53 (average age 46.75 ± 0.56), were examined. Depending on the treatment received, patients were divided into groups: Group I (n = 30) - patients receiving baseline therapy in accordance with guidelines for hypertension [21]; Group ІІ (n = 40) - patients who received on the background of basic therapy magnesium doses of 1 tablet. 3 p / day; Group III (n = 38) - patients received a megacillum dose of 300 mg on the background of basic therapy. 3 p / day; Group IV (n = 37) - Patients taking Mebicer at a dose of 300 mg on baseline therapy. 3 pg / day and magnesium drug in a dose of 1 tab. 3 p / day Duration of therapy - 1 month. The control group included 20 practically healthy people without hypertension, cardiovascular disease and overweight, (average age - 42.58 ± 1.45).

In order to study the influence of the proposed therapeutic complexes in patients with hypertension, psychological interviews were conducted twice, at the beginning and after the completion of treatment. The positive effect of an additional appointment of a mebicer in combination with a magnesium preparation on stress-limiting environmental influences indicated a decrease in the level of depression by 37.39% (group III) and 45.42% (group IV) and alexithymia index and by 10.1 % - anxiety.

The use of magnesium and mebicer drugs allowed to keep the normal ratio of mediator support to the functioning of the higher psychic sphere and the autonomic nervous system in patients with hypertension.

 

Keywords: arterial hypertension, neurotransmitters, alexithymia, a preparation of magnesium, mebicer.

 

Full text: PDF (Rus)

References
  1. Kearney P.M. Global burden of hypertension: analysis of worldwide data. //Lancet . – 2015 – Vol. 365. – P. 217-223.
  2. Effect of obesity on myocardial remodeling in perimenopausal women. Bulletin of St Petersburg State University/A.N. Shishkin, N.V. Khudiakova, N.V. Temnaya, V.V. Smirnov//Vestnik Sankt-Peterburgskogo Universiteta. – 2013. –Vol.11, №4. – 1P.3–22.
  3. Boyko T.Ya. Rol pervynnoi lanky u profilaktytsi arterialnoi hipertenzii sered dorosloho naselennia / T.Ya. Boyko // Zdobutki klinichnoi i eksperymentalnoi medytsyny. – 2016. – № 2. – С. 111-113.
  4. Frolova N.L. Psikhovehetativnye narushenia u bolnykh hipertonicheskoy bolezniu I stadii i vozmozhnost ikh korrektsii /N.L. Frolova, L.S.Chutko, S.Iu. Surushkina // Zhurnal nevrolohii i psikhiatrii. – 2013. –№ 9. – С.43-47.
  5. Cherenko S.М. Patohenetychni varianty pervynnoho hiperaldosteronizmu: analiz klinichnoi serii sposterezhen / S.М. Cherenko, L.V. Schekaturova, А.О. Tovkay // Klinichna endokrynolohia ta endokrynna khirurhia. – 2015. – №4(52). – С. 73–79.
  6. Batushkin І. О. Vidnovlennia pokaznykiv vehetatyvnoi rivnovahy ta harmonizatsia funktsii tserebralnykh i pidkorkovykh struktur shliakhom moduliatsii systemy HAMK u khvorykh z arterialnoiu hipertenzieiu / V.V. Batushkin, І.О. Lavrinchuk // Zaporozhskiy meditsynskiy zhurnal. – 2017. – Т. 19, № 4(103). – С.390-394.
  7. Rakisheva H.T. Issledovanie stress-sistem v henezise formirovania pervichnoy arterialnoy hipertenzii u detey / H.T. Rakisheva //Mezhdunarodnyi nauchnyi zhurnal «Sinerhia nauk» elektronnyi zhurnal http://synergy-journal.ru/archive/article0779
  8. Role of the adaptive immune system in hypertension/D.G. Harrison, A.Vinh, H. Lob , M.S.Madhur //Curr Opin Pharmacol. – 2010. – Vol.10, № 2. – P.203–207.
  9. Ushakov А.V. Patoheneticheskie mekhanizmy formirovania stoykoy arterialnoy hipertenzii pri khronicheskom psikhoemotsyonalnom napriazhenii /А.V. Ushakov, V.S. Ivanchenko, А.А. Haharina// Arterialnaia hipertenzia. – 2016. – Т.22, № 2. – С.128–143.
  10. Kozlova М.А. Kortizol kak marker stressa / М.А. Kozlova, А.I. Kozlov // Fiziolohia cheloveka. – 2014. –Т.40, № 2. – С.123–136.
  11. Sostoianie vazomediatornykh sistem u podrostkov s essentsyalnoy arterialnoy hipertenziey / H.N. Afliatumova, D.I. Sadykova, R.R. Hmatullina [i dr.]//Prakticheskaia meditsyna. – 2016. – №7. – С.20-24.
  12. Kulinichenko М.P. Tsyrkuliruiuschie markery disfunktsii endotelia u podrostkov s arterialnoy hipertenziey, assotsyirovannoy s izbytkom massy tela i ozhyreniem / М.P. Kulichenko, S.А. Ushakova, А.D. Petrushyna, S.М. Kliashev // Meditsynskaia nauka i obrazovanie Urala. – 2015. – № 1. – С. 15-19.
  13. Gamoh S. 5-hydroxytryptamine receptors as targets for drug therapies of vascular-related diseases / S. Gamoh, H. Hisa, R. Yamamoto // Biological and Pharmaceutical Bulletin. – 2013. – Vol. 36, № 9. – Р. 1410-1415.
  14. Bhaskaran S. Molecular interactions of serotonin (5-HT) and endothelin-1 in vascular smooth muscle cells: in vitro and ex vivo analyses / S. Bhaskaran, J. Zaluski, A. Banes-Berceli // Am J Physiol Cell Physiol. – 2014. – Vol. 306, №2. – Р. 43-51.
  15. Psikhosomaticheskie rastroystva v praktike terapevta / pod. pedaktsiey V.I. Simanenkova. – Sankt-Piterburh, SpetsLit, 2008, 359 с.
  16. Hluschenko V.V. Sindrom defitsyta vnimania i hiperaktivnost u patsyentov s arterialnoy hipertenziey/ V.V. Hluschenko // Obzory po klinicheskoy farmakolohii i lekarstvennoy terapii. – 2015. – Т.9, №1. – С.73-77.
  17. Moroz H.Z. Mahniy v suchasniy medytsyni: vid teorii do klinichnoi praktyky / H.Z. Moroz, І.V. Sedchenko //Ukrainsky medychny visnyk/ Therapia. – 2015. – №1 (94). – С. 17.
  18. Fedorova О.А. preparaty kalia i mahnia v sovremennoy klinicheskoy praktike / О.А. Fedorova // Ukrainskiy chasopys. – 2014. – №1. – С.
  19. Tkachenko V.І. Rol kaliiu ta mahniiu pry likuvanni sertsevo-sudynnykh zakhvoriuvan / V.І. Tkachenko, Т.О. Bahro //Liky Ukrainy . – 2016. – №3. – С. 33-36.
  20. Unikalnaia sovokupnost terapevticheskikh effektov dnevnoho trankvilizatora mebikara / I.Е. Zimakova, R.Kh. Humerov, А.М. Karpov [i dr.] / http://health-ua.com/article/18791-unikal-naya-sovokupnost-terapevticheskih-effektov-dnevnogo-trankvilizatora-m
  21. Optymizatsia likuvannia komorbidnoi patolohii ishemichoi khvoroby sertsia i arterialnoi hipertenzii u khvorykh pokhyloho viku / М.М. Potiazhenko, К.E. Ischeykin, Т.V. Nastroha [ta іnsh.] // Ukrainska medychna stomatolohichna akademia. – 2017. – Т. 17, Вип. 2. – С.136-140.
  22. «Arterialna hipertenzia» unifikovanoho klinichnoho protokolu pervynnoi, ekstrenoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy «Arterialna hipertenzia» (Nakaz МОZ Ukrainy vid 24 travnia 2012 roku № 384).
  23. Mancia G.The autonomic nervous system and hypertension/G. Mancia, G. Grassi //Circul Res. – 2014. – Vol.114, №11. – P.1804–1814.
  24. Bolívar JJ. Essential hypertension: an approach to its etiology and neurogenic pathophysiology/J.J. Bolívar //J Hypertens. – 2013. – Vol. 54. – P.780-789.
  25. Chinkin AS. The ratio of adrenaline: noradrenaline and alpha- and beta-adrenergic receptors in the myocardium and adrenergic chronotropic and inotropic response in extreme conditions and adapt/A.S. Chinkin// Nauka i Sport: Sovremennye Tendentsii = Science and Sport: Current Trends. – 2014. – Vol.4, №3). – P.10–18.
  26. Hamer M . Cortisol responses to mental stress and incident hypertension in healthy men and women/M. Hamer,A. Steptoe //J Clin Endocrinol Metab. – 2012. –Vol.97, №1. – P.39-41.